Nitroglycerin - therapeutic uses, routes of administration, adverse effects moa,precaution 2. Coronary Steal Phenomenon - explain, clinical significance precaution 3. Nifedipine and Verapamil - compare and contrast 4. Nitrates - MOA theraputic uses adverse effect precautions

2mbbs pharmacology refer kd t

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
I now have all the content I need for a thorough 2nd MBBS pharmacology answer. Let me compile the comprehensive response.

2nd MBBS Pharmacology - Cardiovascular Drugs

Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics, Lippincott Illustrated Reviews: Pharmacology, Katzung's Basic & Clinical Pharmacology, Braunwald's Heart Disease

1. Nitroglycerin (Glyceryl Trinitrate / GTN)

Mechanism of Action

Nitroglycerin is an organic nitrate that acts as a nitric oxide (NO) donor. The key steps are:
  1. GTN enters vascular smooth muscle and is converted to NO (bioactivation requires mitochondrial aldehyde dehydrogenase, ALDH2).
  2. NO activates soluble guanylyl cyclase (sGC), which converts GTP to cGMP.
  3. Elevated cGMP activates protein kinase G (PKG), which:
    • Reduces myosin light chain kinase (MLCK) activity
    • Increases myosin light chain phosphatase activity
    • Reduces intracellular Ca²⁺
  4. Result: vascular smooth muscle relaxation and vasodilation
Selectivity: At low/therapeutic doses, GTN preferentially dilates venous capacitance vessels (preload reduction) and large conductance coronary arteries. At higher doses, arteriolar dilation also occurs (afterload reduction).

Antianginal MOA - Reduction of O₂ Demand

The dominant antianginal effect is NOT increased O₂ delivery - it is reduced O₂ demand:
EffectMechanismBenefit
VenodilationReduced venous return → decreased preload (↓LVEDP, ↓wall tension - Law of Laplace)↓ O₂ consumption
Arteriodilation (higher doses)Decreased peripheral resistance → ↓afterload↓ Cardiac work
Coronary dilationDilates large epicardial arteries, relieves coronary vasospasm↑ O₂ delivery in Prinzmetal's angina
Subendocardial perfusionReduced LVEDP increases transmural perfusion pressure gradientFavors subendocardial blood flow
Key fact: When GTN is injected directly into the coronary artery, it does NOT abort anginal pain, confirming that its major effect is preload reduction, not direct coronary dilation. - Goodman & Gilman

Therapeutic Uses

  1. Stable angina (exertional) - sublingual GTN for acute relief
  2. Unstable angina (ACS) - IV nitroglycerin for ongoing ischemia
  3. Vasospastic (Prinzmetal's) angina - directly relieves coronary spasm
  4. Acute left ventricular failure / pulmonary edema - venodilation reduces preload and pulmonary congestion; IV dose 20-400 µg/min
  5. Hypertensive emergencies - IV nitroglyerin for BP control
  6. Acute MI - reduces preload and myocardial O₂ demand
  7. Esophageal spasm - smooth muscle relaxation (diagnostic/therapeutic)

Routes of Administration

RouteFormOnsetDurationUse
SublingualTablet / spray1-3 min15-30 minAcute angina attack
Buccal/transmucosalTablet2-3 min3-5 hoursShort-term prophylaxis
OralSustained release30-60 min8-12 hoursProphylaxis
Transdermal patchPatch30-60 min24 hours (apply 12h/day)Prophylaxis
Topical ointment2% ointment15-30 min4-8 hoursProphylaxis
IntravenousInfusionImmediateInfusion-dependentAcute HF, ACS, hypertensive emergency
Note: The sublingual spray may act even faster than the sublingual tablet.

Adverse Effects

  1. Headache - most common; due to meningeal arterial dilation. Usually decreases after a few days of continued use.
  2. Postural hypotension / dizziness / weakness - reflex tachycardia may occur
  3. Flushing - facial/neck vasodilation (low doses can cause facial flush without systemic hypotension)
  4. Reflex tachycardia - baroreceptor-mediated compensatory response to hypotension
  5. Methemoglobinemia - at very high doses (more clinically relevant with sodium nitroprusside/amyl nitrite)
  6. Bezold-Jarisch reflex - paradoxical bradycardia and hypotension with sublingual GTN (vagally mediated)
  7. Nitrate tolerance - with continuous use (see below)
  8. Nitrate dependence - withdrawal angina in industrial workers exposed chronically

Nitrate Tolerance

  • Develops with repeated high-dose/continuous exposure
  • Mechanisms: depletion of sulfhydryl groups, free radical generation, neurohumoral activation (RAAS, sympathetics), plasma volume expansion, ALDH2 inactivation
  • Prevention: Nitrate-free interval of 8-12 hours daily (usually at night for exertional angina)
  • Eccentric twice-daily dosing for ISDN maintains efficacy

Precautions and Contraindications

  1. Sildenafil (and PDE5 inhibitors) - ABSOLUTE CONTRAINDICATION. Both increase cGMP; combined use causes severe, potentially fatal hypotension.
  2. Hypovolemia - preload-dependent states; GTN worsens hypotension
  3. Hypotension (SBP <90 mmHg) - contraindicated
  4. Right ventricular infarction - RV depends on preload; GTN can cause severe hypotension
  5. Hypertrophic obstructive cardiomyopathy (HOCM) - reduces preload, worsens outflow obstruction
  6. Increased intracranial pressure / head injury - meningeal vasodilation worsens ICP
  7. Closed-angle glaucoma - increases intraocular pressure
  8. Autonomic dysfunction (e.g., diabetic autonomic neuropathy) - compensatory sympathetic response impaired; severe hypotension/syncope possible
  9. Abrupt withdrawal - can precipitate rebound angina after chronic use

2. Coronary Steal Phenomenon

Definition

"Coronary steal" refers to the paradoxical diversion of blood flow away from ischemic myocardium toward well-perfused regions when a non-selective coronary arteriolar dilator is administered.

Pathophysiology

In a patient with partial coronary artery obstruction:
  • In ischemic zones: arterioles are already maximally dilated due to local autoregulatory factors (adenosine, CO₂, reduced O₂). They cannot dilate further.
  • In normal zones: arterioles are not maximally dilated and retain vasodilatory reserve.
When a potent arteriolar vasodilator (e.g., dipyridamole, adenosine, isoflurane) is given:
  • Only the normal-zone vessels respond and dilate further
  • Blood is preferentially redirected to the normal zones
  • The ischemic zone loses flow → worsening ischemia
Normal zone: vasodilatory reserve present → DILATES → receives MORE blood
Ischemic zone: already maximally dilated → CANNOT dilate → receives LESS blood ("stolen")

Agents That Can Cause Coronary Steal

  • Dipyridamole - major clinical example; inhibits adenosine uptake, causing widespread arteriolar dilation. Used in pharmacological stress testing precisely because it causes steal.
  • Adenosine and regadenoson - both carry FDA black-box warnings for this effect
  • Sodium nitroprusside - non-selective arteriolar/venous dilator; may cause steal in active MI
  • Isoflurane - historic controversy in anesthetic practice (largely resolved; steal is possible but uncommon at clinical doses)

Clinical Significance

  1. Dipyridamole stress test (pharmacologic stress echo/nuclear scan) exploits coronary steal to provoke ischemia in CAD patients - deliberately induces steal to detect vulnerable myocardium.
  2. In unstable angina, inadvertent coronary steal from dipyridamole can precipitate MI.
  3. In coronary artery fistulas, the fistula creates a steal by diverting blood away from the myocardium, causing angina.
  4. Sodium nitroprusside is not recommended in acute MI patients because its non-selective vasodilation may induce steal.

Precautions

  • Avoid dipyridamole in patients with unstable angina or severe CAD outside of controlled diagnostic settings
  • Dipyridamole stress testing should be performed with resuscitation facilities available; aminophylline (adenosine receptor antagonist) is the antidote to reverse the effect
  • Avoid drugs with non-selective arteriolar dilation in active MI

3. Nifedipine vs. Verapamil - Compare and Contrast

Comparison of calcium channel blockers: coronary dilation, AV conduction, and adverse effect frequency for Nifedipine, Verapamil, and Diltiazem
From Lippincott Illustrated Reviews: Pharmacology - Actions of CCBs

Basic MOA (Common)

All CCBs block voltage-gated L-type Ca²⁺ channels (bind to the α₁ subunit):
  • Nifedipine binds to transmembrane segments of domains III and IV
  • Verapamil binds to transmembrane segment 6 of domain IV (IVS6)
  • Calcium influx blocked → smooth muscle relaxation (vasodilation) + decreased cardiac contractility/conduction

Comparison Table

FeatureNifedipine (Dihydropyridine)Verapamil (Phenylalkylamine)
Drug classDihydropyridine (DHP)Phenylalkylamine
Primary selectivityVascular smooth muscle >> cardiacCardiac > vascular
VasodilationPotent (especially peripheral arterioles)Moderate
Heart rate↑ (reflex tachycardia due to hypotension)↓ (direct negative chronotropy on SA node)
AV conductionMinimal effectStrongly slows AV conduction (↑ PR interval)
Cardiac contractilityMinimal negative inotropySignificant negative inotropy
SA nodeMinimal effectSlows automaticity
Antiarrhythmic useNOT used (no AV node effect)YES - SVT, AF rate control
AnginaYES - vasospastic and stableYES - vasospastic, stable, and unstable
HypertensionPreferred (potent arteriolar dilation)Used but less preferred
Heart failureAvoid (reflex tachycardia worsens demand; negative inotropy)Avoid (negative inotropy)
Adverse effectsHeadache, flushing, dizziness, reflex tachycardia, peripheral edema, gingival hyperplasia (18% adverse effect rate)Constipation, bradycardia, AV block, lassitude, peripheral edema (9% adverse effect rate)
ConstipationNoYes (common dose-dependent ADR)
BioavailabilityLow (first-pass); short-acting short t½~20% oral bioavailability; t½ 4-7 hours
Interaction with digoxinMinimalIncreases digoxin plasma levels (↑ toxicity risk)
Interaction with β-blockersCan combine (heart rate control)Dangerous combination - AV block and severe bradycardia
Use in AV blockSafer (no AV nodal effect)CONTRAINDICATED
Use in WPW + AFNot usedContraindicated (enhances accessory pathway)
Use if VT misdiagnosed as SVTRelatively saferDANGEROUS - can cause hemodynamic collapse
Migraine preventionNot usedYes
Raynaud's phenomenonYES (peripheral vasodilation)Less effective
TocolysisYes (relaxes uterine smooth muscle)Not used for this
HOCMContraindicatedCan be used (reduces outflow obstruction via negative inotropy)

Key Distinguishing Points (Exam Focused)

  • Nifedipine = "vascular selective" → treats HTN and angina; causes reflex tachycardia; NO antiarrhythmic use
  • Verapamil = "cardiac selective" → antiarrhythmic; constipation is hallmark ADR; DO NOT combine with β-blockers or use in AV block
  • Verapamil is the prototype Phenylalkylamine; Nifedipine is the prototype Dihydropyridine
  • Verapamil blocks both activated and inactivated T-type Ca²⁺ channels - frequency/use-dependent block
  • Amlodipine (another DHP) is preferred over short-acting nifedipine in hypertension due to longer t½ (30-50 hours)

4. Nitrates (as a Class)

Members

DrugRouteOnsetDurationKey Use
Nitroglycerin (GTN)SL, transdermal, IV, oral SR1-3 min (SL)15-30 min (SL)Acute angina, ACS
Isosorbide dinitrate (ISDN)SL, oral3-6 min (SL)4-6 hours (oral)Angina prophylaxis
Isosorbide-5-mononitrate (ISMN)Oral only~30-60 min8-12 hoursProphylaxis (no first-pass)
Amyl nitriteInhaled30 sec3-5 minCyanide poisoning (antidote), formerly acute angina
ISMN has high oral bioavailability because it does not undergo significant first-pass hepatic metabolism.

MOA (Class)

All organic nitrates → release NO → activate sGC → ↑ cGMP → activate PKG → ↓ MLCK activity + ↓ intracellular Ca²⁺ → smooth muscle relaxation and vasodilation
The key signaling sequence: Nitrate → NO → sGC → cGMP → PKG → Vasodilation

Therapeutic Uses (Class)

  1. Stable angina - acute relief (SL GTN) and prophylaxis (ISDN, ISMN, transdermal GTN)
  2. Unstable angina - IV GTN reduces ischemia and preload
  3. Prinzmetal's (variant) angina - directly relieves coronary arterial spasm; drug of choice
  4. Acute MI - IV GTN in first 24-48 hours reduces preload, wall stress, infarct size
  5. Acute decompensated heart failure - venodilation rapidly reduces pulmonary congestion
  6. Hypertensive urgency/emergency - IV GTN or ISDN
  7. Esophageal spasm - smooth muscle relaxation
  8. Pulmonary hypertension - inhaled NO in neonates
  9. Anal fissures - topical GTN relaxes internal anal sphincter

Adverse Effects (Class)

ADRMechanism
Throbbing headacheMeningeal arterial dilation (most common; decreases with continued use)
Postural hypotensionVenodilation → reduced venous return → ↓ BP
Reflex tachycardiaBaroreceptor response to hypotension
FlushingFacial/neck vasodilation
Dizziness / syncopeHypotension ("nitrate syncope")
MethemoglobinemiaHigh doses; amyl nitrite and nitroprusside are more relevant
ToleranceContinuous high-dose exposure depletes SH groups, activates RAAS
Withdrawal anginaRebound after chronic use; especially in industrial workers (Monday Disease)
Bezold-Jarisch reflexParadoxical bradycardia + hypotension with SL GTN

Precautions (Class)

SituationReasonAction
PDE5 inhibitors (sildenafil, tadalafil, vardenafil)Both ↑ cGMP → severe synergistic hypotensionABSOLUTE CONTRAINDICATION (at least 24-48h gap)
Right ventricular MIRV preload dependent; venodilation → severe ↓ BPAvoid nitrates
HypovolemiaWorsens hypotensionCorrect volume first
Severe aortic stenosis / HOCMFixed outflow obstruction; venodilation reduces CO severelyAvoid or use cautiously
Hypotension (SBP <90 mmHg)Further BP drop dangerousContraindicated
↑ ICP / head traumaCerebral vasodilation worsens ICPContraindicated
Autonomic dysfunctionCannot compensate for BP dropUse with extreme caution
Glaucoma (closed-angle)May raise IOPAvoid
Tolerance preventionContinuous use → loss of efficacyMaintain 8-12 hour nitrate-free interval
Abrupt withdrawalRebound angina / vasospasmTaper gradually

Nitrate-Free Interval Strategy

  • Exertional angina: remove patch/omit night dose (patient sleeps without nitrate)
  • Nocturnal / rest angina: omit daytime dose instead
  • Always add another antianginal agent (β-blocker or CCB) to cover the nitrate-free period

Summary for Exams:
  • Nitrates/GTN: NO donor → cGMP → vasodilation (mainly venous); key contraindication = PDE5 inhibitors + RV MI
  • Coronary steal: maximum arteriolar dilation in normal zones diverts blood from ischemic zones; caused by dipyridamole, adenosine; used in stress testing; dangerous in unstable angina
  • Nifedipine: vascular-selective DHP; reflex tachycardia; no AV node effect; gingival hyperplasia; 18% ADR rate
  • Verapamil: cardiac-selective; antiarrhythmic; constipation; AV block risk; dangerous with β-blockers + digoxin; 9% ADR rate
This is a shared conversation. Sign in to Orris to start your own chat.